Dystrophin Dp116: A Yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene

Genes - Switzerland
doi 10.3390/genes8100251
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

MDPI AG

Related search

Immune Responses to Dystrophin: Implications for Gene Therapy of Duchenne Muscular Dystrophy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Dual Exon Skipping in Myostatin and Dystrophin for Duchenne Muscular Dystrophy

BMC Medical Genomics
Genetics
2011English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Cardiac Dysfunction in Duchenne Muscular Dystrophy Is Less Frequent in Patients With Mutations in the Dystrophin Dp116 Coding Region Than in Other Regions

Circulation. Genomic and precision medicine
GeneticsCardiovascular MedicineCardiology
2018English

Duchenne Muscular Dystrophy

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy